Capegard 500mg Tab Capecitabine Tablets

Capegard 500mg Tab Capecitabine Tablets

Product Details:

  • Drug Type General Medicines
  • Physical Form Tablets
  • Dosage 500 mg
  • Suitable For Adults
  • Supply Ability : 10000000 Piece Per Week
  • Click to view more
X

Price And Quantity

  • 10000000 Piece
  • 560 INR

Product Specifications

  • Tablets
  • Adults
  • 500 mg
  • General Medicines

Trade Information

  • Cash in Advance (CID), Cash Advance (CA)
  • 10000000 Piece Per Week
  • 1 Week
  • Africa, Middle East, Western Europe, Eastern Europe, South America, North America, Central America, Australia, Asia

Product Description

Capegard - Capegard is an orally-administered chemotherapeutic agent used in the treatment of metastatic breast and colorectal cancers. Capegard is a prodrug, that is enzymatically converted to 5-fluorouracil in the tumor, where it inhibits DNA synthesis and slows growth of tumor tissue. The activation of Capegard follows a pathway with three enzymatic steps and two intermediary metabolites, 5'-deoxy-5-fluorocytidine (5'-DFCR) and 5'-deoxy-5-fluorouridine (5'-DFUR), to form 5-fluorouracil.

Indications: It is used alone or in combination in the adjuvant and palliative treatment of gastrointestinal cancer and breast cancer.

Active ingredients: Capecitabine

Specification

Strength

500 mg

Packaging size

10'S

Brand

Capegard

Composition

Capecitabine 500 mg

Manufacturer

Cipla

Treatment

Cancer

Prescription/Non prescription

Prescription

Form

Tablet

Therapeutic Uses

Used in the treatment of colon, rectal, gastric or breast cancer Used to prevent new occurrence of colon cancer after complete removal of the tumor by surgery

Packaging Type

1 strip in box


  


DHEER HEALTHCARE PRIVATE LIMITED

* Tips on getting accurate quotes. Please include product name, order quantity, usage, special requests if any in your inquiry.



DHEER HEALTHCARE PRIVATE LIMITED All Rights Reserved.(Terms of Use)
Developed and Managed by Infocom Network Ltd.(Terms of Use)
Developed and Managed by Infocom Network Ltd.